News tagged with placebo

Imeglimin beneficial as add-on to metformin in T2DM

(HealthDay)—For patients with type 2 diabetes inadequately controlled by metformin alone, addition of the new oral anti-diabetes agent imeglimin improves glycemic control with good tolerability and safety, ...

Dec 14, 2012
popularity not rated yet | comments 0